World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 March 2022
Main ID:  NCT02478255
Date of registration: 16/06/2015
Prospective Registration: Yes
Primary sponsor: Bastiaan Driehuys
Public title: Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment
Scientific title: Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment
Date of first enrolment: March 21, 2016
Target sample size: 25
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02478255
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  Phase 2
Countries of recruitment
United States
Contacts
Name:     Joseph Mammarappallil, M.D.
Address: 
Telephone:
Email:
Affiliation:  Duke University
Key inclusion & exclusion criteria

Inclusion Criteria for Patients:

1. Patient scheduled to undergo thoracic RT at Duke University to a dose of at least 20
Gy

2. Willing and able to give informed consent and adhere to visit/protocol schedules

Exclusion Criteria for Patients:

1. Subject is less than 18 years old

2. MRI is contraindicated based on responses to MRI Screening questionnaire

3. Subject is pregnant or lactating

4. Respiratory illness of a bacterial or viral etiology within 30 days of MRI

5. Subject has any form of known cardiac arrhythmia

6. Subject does not fit into 129Xe vest coil used for MRI

7. Subject cannot hold his/her breath for 15 seconds

8. Subject deemed unlikely to be able to comply with instructions during imaging

9. Medical or psychological conditions which, in the opinion of the investigator, might
create undue risk to the subject or interfere with the subject's ability to comply
with the protocol requirements

Inclusion/Exclusion Criteria for Healthy Volunteers

1. Subject meets all criteria above but does not have a clinical diagnosis of respiratory
disease.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Radiation Injury
Intervention(s)
Device: MRI
Drug: Hyperpolarized 129-Xenon gas
Primary Outcome(s)
Change in pulmonary function, as measured by ventilation defect percentage (VDP) [Time Frame: Baseline, following RT (up to 12 weeks)]
Secondary Outcome(s)
Change in gas exchange defect percentage (EDP) following RT [Time Frame: Baseline, following RT (up to 12 weeks)]
Change in perfusion defect percentage (PDP) following RT [Time Frame: Baseline, following RT (up to 12 weeks)]
RBC:barrier ratio [Time Frame: Baseline, following RT (up to 12 weeks)]
Secondary ID(s)
1R01HL105643-01
Pro00059856
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Heart, Lung, and Blood Institute (NHLBI)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history